XELJANZ Trademark

Trademark Overview


On Friday, November 22, 2013, a trademark application was filed for XELJANZ with the United States Patent and Trademark Office. The USPTO has given the XELJANZ trademark a serial number of 86126490. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, May 11, 2024. This trademark is owned by Pfizer Inc.. The XELJANZ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

health information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the treatment of pain; on-line information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the treatment of pain
xeljanz

General Information


Serial Number86126490
Word MarkXELJANZ
Filing DateFriday, November 22, 2013
Status800 - REGISTERED AND RENEWED
Status DateSaturday, May 11, 2024
Registration Number4563705
Registration DateTuesday, July 8, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 22, 2014

Trademark Statements


Description of MarkThe mark consists of word "XELJANZ" with starburst design.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Serviceshealth information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the treatment of pain; on-line information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the treatment of pain

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 6, 2013
Primary Code044
First Use Anywhere DateFriday, November 30, 2012
First Use In Commerce DateFriday, November 30, 2012

Trademark Owner History


Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, March 10, 2014ASSIGNED TO EXAMINER
Tuesday, November 26, 2013NEW APPLICATION ENTERED
Friday, December 6, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 7, 2013NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, March 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 2, 2014NOTICE OF PUBLICATION
Tuesday, April 22, 2014PUBLISHED FOR OPPOSITION
Tuesday, July 8, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2019TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 23, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, September 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 23, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 23, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, July 8, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 24, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, May 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 11, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, May 11, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, May 11, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED